Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Caligan Partners LP
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil edges higher as investors weigh renewed Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| (NASDAQ: SABS) | Delayed: 2.62 +0.09 (3.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.53 | 52 Week High | $ | |||
| Open | $2.53 | 52 Week Low | $ | |||
| Day High | $2.62 | P/E | N/A | |||
| Day Low | $2.44 | EPS | $ | |||
| Volume | 309,169 | |||||
